(Q38162153)

30 August 2017

title

Human dendritic cells - stars in the skin (English)

1 reference

30 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24222336%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Eynav Klechevsky

series ordinal

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

21 November 2013

1 reference

European Journal of Immunology

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24222336%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24222336%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24222336%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

3147-3155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24222336%20AND%20SRC:MED&resulttype=core&format=json

Ueber die Nerven der menschlichen Haut

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

E-cadherin: from epithelial glue to immunological regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Identification of a novel population of Langerin+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Epidermal Langerhans cells are derived from cells originating in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Langerhans cells cross-present antigen derived from skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Two distinct types of Langerhans cells populate the skin during steady state and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Harnessing human dendritic cell subsets to design novel vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Functional diversity of human vaginal APC subsets in directing T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

IL-12 receptor β1 deficiency alters in vivo T follicular helper cell response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

A unique dermal dendritic cell subset that skews the immune response toward Th2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Targeting C-type lectin receptors with multivalent carbohydrate ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Antigen-loaded pH-sensitive hydrogel microparticles are taken up by dendritic cells with no requirement for targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Oncology meets immunology: the cancer-immunity cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Antigen presentation by dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

A comparison of murine epidermal Langerhans cells with spleen dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021

A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343790

7 January 2021